Delivery Order SPE2DB22D3301-SPE2DB25FX9LW

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,893.72 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S, a prescription pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Junel FE 1 mg-20 mcg tablets. The contract has a firm fixed price of $3,313.44 and a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product, with a ceiling value of $1,922.14 and a completion date of November 29, 2023. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,142.76, is a delivery order for the medical product "JUNEL FE 1 MG-20 MCG TABLET 28S". The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.12 firm fixed-price contract covers the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceuticals product, with a period of performance through June 20, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,203.45, is for the delivery of a specific pharmaceutical product, JUNEL FE 1 MG-20 MCG TABLET 28S. It is a firm fixed-price delivery order contract with an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,429.36, is a delivery order for JUNEL FE 1 MG-20 MCG TABLET 28S. It is a firm fixed-price contract with a performance period ending on January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,120.63 contract is for the delivery of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product. The contract has a period of performance through October 27, 2023 and is a firm-fixed price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,293.96 firm fixed-price delivery order contract is for the supply of 4566847777 JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4565697672 ! JUNEL FE 1 MG-20 MCG TABLET 28S, a prescription medication. The contract has a ceiling value of $2,121.56 and a completion date of September 6, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9LW
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,159.44, is for the delivery of the pharmaceutical product "JUNEL FE 1 MG-20 MCG TABLET 28S". It is a firm fixed price contract with a completion date of February 4, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

This specific delivery order did not utilize any set-aside designation, indicating open competition.

Generated 5/21/25, 10:02 AM